| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥1.40B | +5.9% |
| Gross profit | ¥0.70B | — |
| Operating income | ¥0.21B | — |
| Net income | ¥0.17B | -29.1% |
| Gross margin | 49.9% | Net margin 11.9% |
| Revenue Q/Q | -20.1% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.70B | 50.1% |
| R&D | ¥0.07B | 5.3% |
| SG&A | ¥0.39B | 27.7% |
| Tax & other | ¥0.04B | 3.2% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
乐普医疗 ・ 南风股份 ・ 探路者 ・ 莱美药业 ・ 汉威科技 ・ 天海防务 ・ 安科生物 ・ ST豆神 ・ 鼎汉技术 ・ 华测检测 ・ 新宁物流 ・ 北陆药业
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies